Key Metrics
CiteScore 

1
Recommended pre-submission checks
Powered by 

Topics Covered on JTO Clinical and Research Reports
JTO Clinical and Research Reports Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2000 |
| Publication Time | 19 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Association for the Study of Lung Cancer |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in JTO Clinical and Research Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in JTO Clinical and Research Reports
Toward Global Integration of Exercise in Lung Cancer Care: The IREX-Lung Initiative
- 1 Nov 2026
- JTO Clinical and Research Reports
Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis.
- 1 Nov 2026
- JTO clinical and research reports
High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in EGFR-Mutant NSCLC: A Multicenter Real-World Validation Study (WJOG 20724L)
- 1 Nov 2026
- JTO Clinical and Research Reports
Lung-Reporting and Data System Category (Lung-RADS) and Adherence to Low-Dose Computed Tomography Screening and Recommended Follow-Up: A Multicenter Cohort Study.
- 1 Nov 2026
- JTO clinical and research reports
Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial
- 1 Nov 2026
- JTO Clinical and Research Reports
Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study
- 1 Nov 2026
- JTO Clinical and Research Reports
Toward Global Integration of Exercise in Lung Cancer Care: The IREX-Lung Initiative
- 1 Nov 2026
- JTO Clinical and Research Reports
Dual Checkpoint Inhibition With or Without Chemotherapy in Metastatic NSCLC: A Reconstructed Individual Patient Data Meta-Analysis.
- 1 Nov 2026
- JTO clinical and research reports
High PD-L1 Expression and Clinical Outcomes of First-Line Osimertinib in EGFR-Mutant NSCLC: A Multicenter Real-World Validation Study (WJOG 20724L)
- 1 Nov 2026
- JTO Clinical and Research Reports
Lung-Reporting and Data System Category (Lung-RADS) and Adherence to Low-Dose Computed Tomography Screening and Recommended Follow-Up: A Multicenter Cohort Study.
- 1 Nov 2026
- JTO clinical and research reports
Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial
- 1 Nov 2026
- JTO Clinical and Research Reports
Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study
- 1 Nov 2026
- JTO Clinical and Research Reports